Invention Grant
- Patent Title: Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy
-
Application No.: US14405996Application Date: 2013-06-14
-
Publication No.: US10526290B2Publication Date: 2020-01-07
- Inventor: Helmut Schickaneder , Christian Schickaneder , Armin Buschauer , Stefan Huber , Michael Limmert , Günther Bernhardt , Mathias Lubbe , Harald Hofmeier
- Applicant: SYNBIAS PHARMA AG
- Applicant Address: CH Schaffhausen
- Assignee: SYNBIAS PHARMA AG
- Current Assignee: SYNBIAS PHARMA AG
- Current Assignee Address: CH Schaffhausen
- Agency: Potomac Law Group, PLLC
- International Application: PCT/EP2013/062347 WO 20130614
- International Announcement: WO2013/189847 WO 20131227
- Main IPC: A61K31/4184
- IPC: A61K31/4184 ; C07D235/16 ; C07C231/02
Abstract:
The present invention relates to bendamustine derivatives and related compounds of formula (VII), (VIII) and (IX), and medical uses thereof in particular in cancer therapy.
Public/Granted literature
- US20150152066A1 BENDAMUSTINE DERIVATIVES AND RELATED COMPOUNDS, AND MEDICAL USE THEREOF IN CANCER THERAPY Public/Granted day:2015-06-04
Information query
IPC分类:
